Analysis of prognostic markers in serous ovarian cancer following neoadjuvant chemotherapy

被引：0
|
作者：
Mathur, S. R. [1 ]
Khandakar, B. [1 ]
Kumar, L. [2 ]
Kumar, S. [3 ]
Iyer, V. K. [1 ]
Gupta, S. Datta [1 ]
机构：
[1] AIIMS, Dept Pathol, New Delhi, India
[2] AIIMS, Dept Med Oncol, New Delhi, India
[3] AIIMS, Dept Obstet & Gynaecol, New Delhi, India
来源：
HISTOPATHOLOGY | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
306
引用
收藏
页码：106 / 107
页数：2
相关论文
共 50 条
  • [31] Neoadjuvant chemotherapy for the management of ovarian cancer
    Schwartz, PE
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2002, 16 (04) : 585 - +
  • [32] The role of neoadjuvant chemotherapy in ovarian cancer
    Elies, Antoine
    Riviere, Sophie
    Pouget, Nicolas
    Becette, Veronique
    Dubot, Coraline
    Donnadieu, Anne
    Rouzier, Roman
    Bonneau, Claire
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (06) : 555 - 566
  • [33] Neoadjuvant chemotherapy for advanced ovarian cancer
    Surwit, E
    Childers, J
    Atlas, I
    Nour, M
    Hatch, K
    Hallum, A
    Alberts, D
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1996, 6 (05) : 356 - 361
  • [34] Procoagulant activity in high grade serous ovarian cancer patients following neoadjuvant chemotherapy-The role of the activated protein C pathway
    Ward, Mark P.
    Saadeh, Feras Abu
    O'Toole, Sharon A.
    O'Leary, John J.
    Gleeson, Noreen
    Norris, Lucy A.
    THROMBOSIS RESEARCH, 2021, 200 : 91 - 98
  • [35] Gene expression profiles of ovarian serous carcinoma after neoadjuvant chemotherapy
    Shaw, PA
    Agochiya, M
    Sharma, M
    Murphy, J
    Rosen, B
    Brown, TJ
    Begley, H
    Jurisica, I
    LABORATORY INVESTIGATION, 2006, 86 : 195A - 196A
  • [36] Gene expression profiles of ovarian serous carcinoma after neoadjuvant chemotherapy
    Shaw, PA
    Agochiya, M
    Sharma, M
    Murphy, J
    Rosen, B
    Brown, TJ
    Begley, H
    Jurisica, I
    MODERN PATHOLOGY, 2006, 19 : 195A - 196A
  • [37] Improved T-cell Immunity Following Neoadjuvant Chemotherapy in Ovarian Cancer
    Liu, Min
    Tayob, Nabihah
    Penter, Livius
    Sellars, MacLean
    Tarren, Anna
    Chea, Vipheaviny
    Carulli, Isabel
    Huang, Teddy
    Li, Shuqiang
    Cheng, Su-Chun
    Le, Phuong
    Frackiewicz, Laura
    Fasse, Julia
    Qi, Courtney
    Liu, Joyce F.
    Stover, Elizabeth H.
    Curtis, Jennifer
    Livak, Kenneth J.
    Neuberg, Donna
    Zhang, Guanglan
    Matulonis, Ursula A.
    Wu, Catherine J.
    Keskin, Derin B.
    Konstantinopoulos, Panagiotis A.
    CLINICAL CANCER RESEARCH, 2022, 28 (15) : 3356 - 3366
  • [38] Clinical Significance of Nodal Positivity Following Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer
    Khalid N.
    Dessai S.B.
    Anilkumar B.
    Dharmarajan A.
    Yadav P.
    Arvind S.
    Satheeshan B.
    Indian Journal of Gynecologic Oncology, 2017, 15 (4)
  • [39] The prognostic significance of chemotherapy response score and lymphocytic infiltration in patients with ovarian cancer treated with neoadjuvant chemotherapy
    Rodolakis, J.
    Prodromidou, A.
    Thomakos, N.
    Sotiropoulou, M.
    Liontos, M.
    Haidopoulos, D.
    Rodolakis, A.
    Loutradis, D.
    Bamias, A.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2022, 270 : E34 - E34
  • [40] The prognostic value of chemotherapy response score and lymphocytic infiltration ovarian cancer patients treated with neoadjuvant chemotherapy
    Liontos, M.
    Sotiropoulou, M.
    Kaparelou, M.
    Tzannis, K.
    Tsironis, G.
    Kyriazoglou, A.
    Tsiara, A.
    Zakopoulou, R.
    Rodolakis, I.
    Koutsoukos, K.
    Zagouri, F.
    Thomakos, N.
    Haidopoulos, D.
    Rodolakis, A.
    Bamias, A.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 83 - 84
12345